Related Experiment Video
Updated: May 27, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Primary aldosteronism: who should be screened?
S Monticone1, A Viola, D Tizzani
1Department of Medicine and Experimental Oncology, D ivision of Internal Medicine and Hypertension, University of Torino, Torino, Italy.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|November 29, 2011
Summary
Screening for primary aldosteronism (PA), a common cause of secondary hypertension, should expand beyond current guidelines. Recent research suggests additional patient groups may benefit from PA screening, improving cardiovascular outcomes.
Area of Science:
- Endocrinology
- Hypertension Research
- Clinical Medicine
Background:
- Primary aldosteronism (PA) is the most common cause of secondary hypertension, affecting 5-10% of hypertensive patients.
- The main subtypes, aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia (BAH), comprise 95% of PA cases.
- Current diagnosis involves screening, confirmation, and subtype differentiation, with established risk categories.
Purpose of the Study:
- To review and expand upon the Endocrine Society's guidelines for primary aldosteronism screening.
- To identify additional patient populations with potentially high PA prevalence based on recent research.
- To optimize early diagnosis and management of PA for improved patient outcomes.
Main Methods:
- Review of existing Endocrine Society guidelines for PA diagnosis.
- Analysis of recent studies linking PA with metabolic syndrome, diabetes, and sleep apnea.
- Discussion of expanded screening criteria for primary aldosteronism.
Main Results:
- Established PA screening criteria include specific hypertension stages, hypokalemia, adrenal incidentalomas, and family history.
- Emerging research links PA to metabolic syndrome, diabetes, and obstructive sleep apnea.
- These comorbidities may contribute to increased cardiovascular and cerebrovascular events in PA patients.
Conclusions:
- Current PA screening guidelines should be considered alongside emerging evidence.
- Expanding screening to include patients with metabolic syndrome, diabetes, and sleep apnea is warranted.
- Early detection and management of PA can mitigate associated cardiovascular risks.
Related Concept Videos
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...